Multidimensional outcomes analysis of intrathecal, oral opioid, and behavioral-functional restoration therapy for failed back surgery syndrome: A retrospective study with 4 years' follow-up

Neuromodulation

Volumn 9, Issue 4, 2006, Pages 270-283

  Doleys, Daniel M ^a   Brown, Jessica L ^b   Ness, Timothy ^c  

^a Pain and Rehabilitation Institute   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Behavioral therapy; Intrathecal therapy; Low back pain; Opioid; Outcomes

Indexed keywords

ANALGESIC AGENT; ANESTHETIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; DEXTROPROPOXYPHENE; HYDROCODONE; METHADONE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYCODONE;

ABSENCE OF SIDE EFFECTS; ANALYSIS OF VARIANCE; ARTICLE; BEHAVIOR THERAPY; CHI SQUARE TEST; CONTROLLED STUDY; DEMOGRAPHY; DRUG DELIVERY SYSTEM; DRUG USE; FOLLOW UP; HUMAN; IMPLANT; INTERMETHOD COMPARISON; INTERVIEW; LOW BACK PAIN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATIENT SATISFACTION; QUESTIONNAIRE; RETROSPECTIVE STUDY; SPINE SURGERY; STUDENT T TEST; TREATMENT FAILURE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 33748742254     PISSN: 10947159     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1403.2006.00069.x     Document Type: Article

References (67)

1. Bombardier C (ed.). Focus issue: outcomes assessment in the evaluation of treatment for spinal disorders. Spine 2000;25:3097-3202.
2. Doleys DM. Outcomes. SPS Newsletter 2002; winter: 4-7.
3. Deyo RA, Battie M, Beurkens AH et al. Outcome measures for low back pain research: a proposal for standardized use. Spine 1998;23:2003-2013.
4. Bombardier C. Outcome assessment in the evaluation of treatment of spinal disorders: summary and general recommendations. Spine 2000;25:3097-3103.
5. Turk DC, Dworkin RR, Allen N et al. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain 2003;106:337-345.
6. Brown J, Klapow J, Doleys DM, Lowery DL, Tutak U. Disease-specific and generic health outcome: a model for the evaluation of long-term intrathecal opioid therapy in noncancer low back pain patients. Clin J Pain 1999;15:122-134.
7. Harstall C, Ospina M. How prevalent is chronic pain? Pain: Clin Updates 2003;11:1-4.
8. Doleys DM. Psychological considerations in spine surgery. In: Follett KA, ed. Neurosurgical pain management. Philadelphia: Elsevier Saunders Press, 2004:38-45.
9. Paice JA, Penn RD, Shott S. Intraspinal morphine for chronic pain: a retrospective, multicenter study. J Pain Symptom Manage 1996;11:71-80.
10. Doleys DM, Coleton M, Tutak U. Use of intrathecal infusion therapy on noncancer pain patients: follow-up and comparison of workers compensation versus nonworkers compensation patients. Neuromodulation 1998;1:149-159.
11. Smith TJ, Staats PS, Deer T et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol 2002;20:4040-4049.
12. Penn RD. Neuraxial analgesic administration. In: Follett KA, ed. Neurosurgical pain management. Philadelphia: Elsevier Saunders Press, 2004:150-155.
13. Follett KA, Burchiel K, Deer T et al. Prevention of intrathecal drug delivery catheter-related complications. Neuromodulation 2003;6:31-41.
14. Harden N. Chronic opioid therapy: another reappraisal. Am Pain Soc Bull 2002;12:3-6.
15. Turk DC, Brody MC, Okifuji EA. Physicians' attitudes and practices regarding the long-term prescribing of opioids for noncancer pain. Pain 1994;59:201-208.
16. Allan L, Richarz U, Simpson K, Slappendel R. Transdermal fentanyl vs sustained release oral morphine in strong-opioid naïve patients with chronic low back pain. Spine 2005;30:2484-2490.
17. Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Eng J Med 2003;349:1943-1953.
18. Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic noncancer pain: systematic review of efficacy and safety. Pain 2004;112:372-380.
19. Fillingim RB, Doleys DM, Edwards RR, Lowery D. Clinical characteristics of chronic back pain as a function of gender and oral opioid use. Spine 2003;28:143-150.
20. Truk DC, Okifuji A. Treatment of chronic pain patients: clinical outcomes, cost-effectiveness, and cost-benefits of multidisciplinary pain centers. Crit Rev Phys Med Rehabil 1998;10:181-208.
21. Flor H, Fydrich T, Turk DC. Efficacy of multidisciplinary pain treatment center: a meta-analytic review. Pain 1992;49:221-230.
22. Morley S, Eccleston C, Williams AC. Systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy and behavior therapy for chronic pain in adults, excluding headache. Pain 1999;80:1-13.
23. Chapman SL. Outpatient rehabilitation programs for patients with chronic pain. In: Tollison CD, Sattwethwaite JR, Tollison JW, eds. Practical pain mangement. Philadelphia: Lippincott Williams & Wilkins, 2002:769-781.
24. Farrar JT, Young JP, LaMoreaux L, Werth JL, Poole RM. Clinical importance of change in chronic pain intensity measured on an 11 point numerical rating scale. Pain 2001;94:149-158.
25. Farrar JT, Berlin JA, Strom BL. Clinically important changes in acute pain outcome measures: a validation study. J P ain Symptom Manage 2003;25:406-411.
26. Cepeda MS, Africano JM, Polo R, Alcala R, Carr D. What decline in pain intensity is meaningful to patients with acute pain? Pain 2003;105:151-171.
27. Tutak U, Doleys DM. Intrathecal infusion systems for treatment of chronic low back and leg pain of noncancer origin. South Med J 1996;89:295-300.
28. Rosenbaum PR. Optimal matching for observational studies. J Am Stat Assoc 1989;84:1024-1032.
29. Krames ES, Schuchard M. Implantable intraspinal infusion analgesia: management guidelines. Pain Rev 1995;2:267-278.
30. Omoigui S. The anesthesia drugs handbook. St. Louis, MO: Mosby, 1995.
31. Melzack R, Katz J. Pain assessment in persons in pain. In: Wall PD, Melzack RL, eds. Textbook of pain. London: Churchhill and Livingstone, 1999:409-426.
32. Fairbank JC, Davies JB, Cooper J, O'brien JP. Oswestry low back pain disability questionnaire. Physiotherapy 1980;66:271-278.
33. Gronbald M, Jarvinen E, Hurn E. Relationship of the Pain Disability Index (PDI) and the Oswestry Disability Questionnaire (ODQ) with three dynamic physical tests in a group of patient with chronic low back and leg pain. Clin J Pain 1994;10:197-203.
34. Beck A, Ward CH, Mock J, Erlbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:53-63.
35. Beck A, Stein EA, Garbin MG. Psychometric properties of the beck depression inventory: twenty-five years of evaluation. Clin Psychol Rev 1988;8:77-100.
36. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1975;1:277-299.
37. Melzack R, Katz J. The McGill Pain Questionnaire: appraisal and current status. In: Turk DC, Melzack R, eds. Handbook of pain assessment. New York: Gillford Press, 2001:35-52.
38. Kaplan RM, Bush JW, Berry CC. Health status: types of validity and the index of well-being. Health Serv Res 1976;11:478-507.
39. Kaplan RM, Sieber W, Ganiats T. The Quality of Well-being Scale: comparison of the interview-administered version with a self-administered questionnaire. Psychol Health 1997;12:788-791.
40. Ware JE. SF-36 health survey: manual and interpretation guide. Boston: The Health Institute, 1993.
41. Ware JE, Kosinski M, Bayliss MS. Comparison of methods of scoring and statistical analysis of the SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 1995;33:AS264-AS279.
42. Fryback DG, Lawrence WF, Martin PA, Klien R, Klein HE. Predicting Quality of Well-being scores from the SF-36: results from the Beaver Dam Health Outcomes Study. Med Decis Making 1997;17:1-9.
43. Ware JE, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A. Comparison of methods of scoring and statistical analysis of the SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 1998;33A:AS264-AS279.
44. Revicki DA, Wood M, Maton PN, Sorensen S. The impact of gastroesophageal reflux disease on health-related QoL. Am J Med, 1998;104:252-258.
45. Todd HK. Clinical versus statistical significance in the assessment of pain relief. Ann Emerg Med 1996;27:439-411.
46. Todd KH, Funk JP. The minimum clinically important difference in physician-assigned visual analog pain scores. Acad Emerg Med 1996;3:142-146.
47. Monhemius R, Simpson BA. Efficacy of spinal cord stimulation for neuropathic pain: assessment of abstinence. Euro J Pain 2003;7:513-519.
48. Jensen MP, Mendoza T, Hanna DB, Chen C, Cleelend SC. The analgesic effects that underlie patient satisfaction with treatment. Pain 2004;110:480-487.
49. Jamison RN, Raymond SA, Sawlsby EA, Nedeljkovic SS, Katz NP. Opioid therapy in chronic noncancer low back pain. A randomized prospective study. Spine 1998;23:2591-2600.
50. Vlaeyen JWS, De Jong J, Geilen M, Heuts PHTG, Van Breukelen G. Graded exposure in vivo in the treatment of pain-related fear: a replicated single case experimental design of four patients with chronic low back pain. Behav Res Ther 2001;39:151-166.
51. Rainville P, Duncan GH, Price DD, Carrier B, Buschnell MC. Pain affect encoded in human anterior cingulate but not somatosensory cortex. Science 1997;277:968-971.
52. Winkelmuller M, Winkelmuller W. Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J Neurosurg 1996;85:458-467.
53. Fester CB. A functional analysis of depression. Am Psychologist 1973;28:857-870.
54. Wittink H, Turk DC, Carr DB, Sukiennik A, Rogers W. Comparison of the redundancy-reliability, and responsiveness to change among SF-36, Oswestry Disability Index, and Multidimentional Pain Inventory. Clin J Pain 2004;20:133-142.
55. Hagen EM, Svensen E, Eriksen HR, Ihlebaek CM, Ursin H. Comorbid subjective health complaints in low back pain. Spine 2006;31:1491-1495.
56. Siddall PJ, Cousins MJ. Persistent pain as a disease entity: implications for clinical management. Anesth Analg 2004;99:510-520.
57. Hassenbusch S, Burchiel K, Coffey RJ et al. Management of intrathecal catheter-tip inflammatory masses: a consensus statement. Pain Med 2002;3:313-323.
58. Hassenbusch SJ, Protenoy RK, Cousins M et al. Polyanalgesic consensus conference 2003: an update on the management of pain by intraspinal drug delivery - report of an expert panel. J Pain Symptom Manage 2004;27:540-563.
59. Sylvester RK, Lindsey SM, Schauer C. The conversion challenge: from intrathecal to oral morphine. Am J Hosp Palliat Med 2004;21:143-147.
60. Lotsch J, Geisslinger G. Current evidence for a genetic modulation of the response to analgesics. Pain 2006;121:1-5.
61. Serlin RC, Mendosa TR, Nakamura Y, Edwards K, Cleeland CS. When is cancer pain mild moderate or severe? Grading pain severity by its interference with function. Pain 1995;61:277-284.
62. Willis KD, Doleys DM. The effects of long-term intraspinal infusion therapy with noncancer pain patients: evaluation of patient, significant-other and clinic staff appraisals. Neuromodulation 1999;2:241-253.
63. Anderson KC, Carlson C, Shatin D. Outcomes of spinal cord stimuluation: patient validation. Neuromodualtion 2001;4:11-17.
64. Vaine I, Crombez G, Eccleston C, Devulder J, DeCorte W. Acceptance of the unpleasant reality of chronic pain: effects upon attention to pain and engagement with daily activities. Pain 2004;112:282-288.
65. McCracken LM, Eccleston C. Coping or acceptance: what to do about chronic pain. Pain 2003;105:197-204.
66. Price DD. Psychological mechanisms of pain and analgesia. Seattle, WA: IASP Press, 1999.
67. Price DD, Bushnell MC (eds). Psychological methods of pain control: basic science and clinical perspectives. Seattle, WA: IASP Press, 2004.